Monodisperse or uniformly sized microparticles offer various advantages over polydisperse ones. Spherical monodisperse particles, combined with a tightly controlled particle size distribution have a significant positive effect on injectability1, flowability2 and release profiles3. With these three key attributes the delivery and performance of APIs can be enhanced.
ApiBead™ is developed to deliver just that: monodisperse, perfectly shaped spheres with a tuneable controlled particle size distribution at CV<10%:
1. Sarmadi et al., Science Adv., 2020, 6, eabb6594.
2. Liu et al., Int. J. Pharm., 2008, 362, 109.
3. Berkland et al., J. Control. Release, 2002, 82, 137.
* These lists are exemplary and non-exhaustive. Please contact us to discuss your API or excipient of interest.
What better way to explore the unique benefits of ApiBead™ beads with a team of experts?
Leave your details and we will contact you to explore together.